D-23129: A potent anticonvulsant in the amygdala kindling model of complex partial seizures

European Journal of Pharmacology

Volumn 303, Issue 3, 1996, Pages 163-169

  Tober, Christine ^a   Rostock, Angelika ^a   Rundfeldt, Chris ^a   Bartsch, Reni ^a  

^a ASTA MEDICA AG   (Germany)

Author keywords

afterdischarge threshold; amygdala kindling; anti epileptic drug; D 23129; valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; N [2 AMINO 4 (4 FLUOROBENZYLAMINO)PHENYL] CARBAMIC ACID ETHYL ESTER; NEW DRUG; RETIGABINE; UNCLASSIFIED DRUG; VALPROIC ACID;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EPILEPTIC DISCHARGE; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MOTOR DYSFUNCTION; NONHUMAN; OPEN FIELD BEHAVIOR; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEIZURE THRESHOLD;

EID: 0029891002     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00073-8     Document Type: Article

References (26)

1. Dailey, J.W., J.H. Cheong, K.H. Ko, L.E. Adams-Curtis and P.C. Jobe, 1995, Anticonvulsant properties of D-20443 in genetically epilepsyprone rats: Prediction of clinical response, Neurosci. Lett. 195, 77.
2. Freeman, F.G. and M.F. Jarvis, 1981, The effect of interstimulation interval on the assessment and stability of kindled seizure threshold, Brain Res. Bull. 7, 629.
3. Goddard, G.V., D.C. McIntyre and C.K. Leech, 1969, A permanent change in brain function resulting from daily electrical stimulation, Exp. Neurol. 25, 295.
4. Löscher, W. and D. Hönack, 1991, Response to NMDA receptor antagonists altered by epileptogenesis, Trends Pharmacol. Sci. 12, 52.
5. Löscher, W. and D. Schmidt, 1988, Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations, Epilepsy Res. 2, 145.
6. Löscher W. and D. Schmidt, 1993, New drugs for the treatment of epilepsy, Curr. Opin. Invest. Drugs 2, 1067.
7. Löscher, W. and D. Schmidt, 1994, Strategies on antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res. 17, 95.
8. Löscher, W., R. Jäckel and S.J. Czuczwar, 1986, Is amygdala kindling in rats a model for drug-resistant partial epilepsy? Exp. Neurol. 93, 211.
9. Löscher, W., C. Rundfeldt and D. Hönack, 1993, Pharmacological characterization of phenytoin-resistant amygdala kindled rats, a new model of drag-resistant partial epilepsy. Epilepsy Res. 15, 207.
10. McNamara, J.O., D.W. Bonhaus and C. Shin, 1993, The kindling model of epilepsy, in: Epilepsy: Models, mechanisms, and concepts, ed. P. A. Schwartzkroin (University Press, Cambridge) p. 27.
11. Moia L.J.M.P., H. Matsui, G.A.M. DeBarros, K. Tomizawa, K. Miyamoto, Y. Kuwata, M. Tokuda, T. Itano and O. Hatase, 1994, Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat, Brain Res. 648, 337.
12. Nickel, B., A. Shandra, L. Godlevsky, A. Mazarati, H. Kupferberg and I. Szelenyi, 1993a, Antiepileptic effects of a new drug: D-20443, Epilepsia 34 (suppl. 2), 95.
13. Nickel, B., A. Shandra, L. Godlevsky, A. Mazarati, H. Kupferberg and I. Szelenyi, 1993b, Anticonvulsant activity of D-20443, Naunyn-Schmiedenberg's Arch. Pharmacol. 347 (suppl.), R142.
14. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates, 2nd edn. (Academic Press, London).
15. Racine, R.J., 1972, Modification of seizure activity by electrical stimulation: II. Motor seizure, Electroenceph. Clin. Neurophysiol. 32, 295.
16. Rostock, A., W. Löscher, C. Tober, C. Rundfeldt and R. Bartsch, 1996, D-23129: a new anticonvulsant with a broad spectrum of activity in animal models of epilepsy, Epilepsy Res., in press.
17. Rundfeldt, C., D. Hönack and W. Löscher, 1990, Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats, Neuropharmacology 29, 845.
18. Rundfeldt, C., C. Tober, A. Rostock and R. Bartsch, 1994, The phenylcarbamic acid ester D-23129 elevates potently the threshold for amygdala kindled seizures in rats at nontoxic doses, Epilepsie-Blätter 7, 29.
19. Rundfeldt, C., A. Rohlfs and R. Netzer, 1995, Multiple actions of the new anticonvulsant D-23129 on voltage gated inward currents and GABA-induced currents in cultured neuronal cells, Naunyn-Schmiedeberg's Arch. Pharmacol. 351 (suppl.), R 160.
20. Seamann, C.A., P.H. Sheridan, J. Engel, M. Molliere, P.K. Narang and F.J. Nice, 1986, Flupirtine, in: New Anticonvulsant Drugs, eds. B.S. Meldrum, B.S. and R.J. Porter (Libbey, London) p. 135.
21. Seydel, J.K., K.-J. Schaper, E.A. Coats, H.P. Cordes, P. Emig, J. Engel, B. Kutscher and E.E. Polymeropoulos, 1994, Synthesis and quantitative structure-activity relationship of anticonvulsant 2,3,6-triamino-pyridines, J. Med. Chem. 37, 3016.
22. Stark, L.G., S.L. Peterson and T.E. Albertson, 1990, Pharmacological and toxicological evaluation of potential antiepileptic drugs in the kindling model of epilepsy, in: Kindling 4, ed. J.A. Wada (Plenum Press, New York) p. 267.
23. Tober, C., A. Rostock and R. Bartsch, 1994a, The phenylcarbamic acid ester D-23129 is highly effective against amygdala kindled seizures in rats, Eur. J. Neurosci. 7 (suppl.), 212.
24. Tober, C., C. Rundfeldt, A. Rostock and R. Bartsch, 1994b, The phenylcarbamic acid ester D-23129 is highly effective in epilepsy models for generalized and focal seizures at nontoxic doses, Soc. Neurosci. Abstr. 20, 1641.
25. Wada, J.A., 1986, Kindling III, Raven Press, New York.
26. Yonekawa, W.D., E.M. Kapetanovic and H.J. Kupferberg, 1995, The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro, Epilepsy Res. 20, 137.